Nasdaq denies Aksys request for continued listing; company appealing

By Ted A. Knutson

Washington, Dec. 30 - Aksys, Ltd. announced Friday it received notice from The Nasdaq Stock Market Tuesday that the company's request for continued listing on The Nasdaq National Market has been denied.

The notice said the company's securities will be delisted unless the firm requests a hearing.

Aksys said it is requesting a hearing before the Nasdaq Listing Qualifications Panel to review the Nasdaq staff's determination. The company's hearing request will stay the delisting until the hearing process is completed.

Aksys is a Lincolnshire, Ill., producer of hemodialysis products for patients suffering from kidney failure.

The announcement was made in an 8-K filing with the Securities and Exchange Commission.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.